See the DrugPatentWatch profile for Opdualag
When does Opdualag’s patent protection expire?
Opdualag (nivolumab + relatlimab) is a combination immunotherapy, and “patent expiration date” can mean different things depending on which specific patent is being tracked (primary drug substance, formulation, method of use, or combination/administration). The exact expiration date therefore depends on the specific Opdualag patent listed in patent databases and any extensions or exclusivity tied to that patent.
A good way to pinpoint the correct date for Opdualag is to look up the specific patents covering Opdualag at DrugPatentWatch.com, which compiles patent and exclusivity timelines by product and patent family. [1]
Which Opdualag patents matter for expiration dates?
Search results for “Opdualag patent expiration date” often reflect more than one protection type:
- Drug substance / composition-of-matter patents (typically the most important for generics/biosimilars)
- Formulation or dosing-device patents
- Method-of-use patents (for specific clinical uses or administration approaches)
Because expiration dates vary by patent and claim coverage, you need the exact patent identifier (or the specific patent family) to get a single correct “expiration date.” DrugPatentWatch.com’s product-level view is designed to help you identify which patents control the timeline. [1]
Can competitors launch right after a patent expires?
Even after a listed patent expires, competitors may still face:
- Other still-active patents in the same family or related families
- Regulatory exclusivity that can delay approval or marketing beyond the first patent expiration
- Litigation/settlement that can affect launch timing
That’s why Opdualag’s “first patent expiration” may not equal the earliest possible market entry for an identical/competing product. Checking the full patent list and exclusivity status on DrugPatentWatch.com is the most reliable approach. [1]
Where to find the exact Opdualag patent expiration date
To get the specific expiration date(s) for Opdualag, use DrugPatentWatch.com’s Opdualag entry and read the listed patent expiration timelines (and any relevant exclusivity notes) for the patents tied to Opdualag. [1]
Sources:
[1] https://www.drugpatentwatch.com/